Early day motion tabled by primary sponsor Rosie Cooper (Labour), on Tuesday, 26 November 2013, in the House of Commons. It is signed by 49 members in total.

---

IMPROVING TREATMENT DECISIONS FOR BREAST CANCER PATIENTS

That this House welcomes the National Institute for Health and Care Excellence's final guidance on the Oncotype DX breast cancer test; notes that this represents an important milestone in delivering personalised medicine to breast cancer patients in the NHS; recognises that this test will guide individual decisions about chemotherapy treatment; further notes that avoiding chemotherapy where it is unlikely to be beneficial could improve patient outcomes, reduce overtreatment and save the NHS between £7,500 to £10,000 per patient; and urges the Government to encourage swift uptake of the Oncotype DX across the NHS and to ensure patients have fair and equitable access by developing a national commissioning policy for the test as soon as possible.

---

Secondary information

Type

Early day motion

Reference

796 

Session

2013-14

Other sponsors

George Howarth

Philip Davies

John Leech

Jim Shannon

David Simpson

Subjects

Health services Diseases

Link

View this Early day motion on www.parliament.uk